<!doctype html><html><head><meta charset=utf-8><title>Intense Vitamin D Testing followed by modest prescriptions resulted in slow improvement in Vitamin D</title>
<link rel=stylesheet href="/css/main.css?v=1748177522"><link rel=stylesheet href="/css/pagination.css?v=1748177522"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748177522"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Intense Vitamin D Testing followed by modest prescriptions resulted in slow improvement in Vitamin D</h1><time>July 14, 2024</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#intense-testing-and-use-of-vitamin-d-supplements-leads-to-slow-improvement-in-vitamin-d-adequacy-rates-a-cross-sectional-analysis-of-real-world-data>Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data</a></li></ul></li></ul></li></ul></nav><hr><h4 id=intense-testing-and-use-of-vitamin-d-supplements-leads-to-slow-improvement-in-vitamin-d-adequacy-rates-a-cross-sectional-analysis-of-real-world-data>Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data</h4><p>Nutrients 2024, 16(1), 111; <a href=https://doi.org/10.3390/nu16010111>https://doi.org/10.3390/nu16010111</a></p><p>Rodis D. Paparodis 1,2,3,4,*ORCID,Dimitra Bantouna 3,Evangelos Karvounis 5,Ioannis Zoupas 6ORCID,Sarantis Livadas 3,7,8,Nicholas Angelopoulos 3,9ORCID,Shahnawaz Imam 2ORCID,Dimitrios T. Papadimitriou 3,10ORCID and Juan C. Jaume 4</p><p>Background: Vitamin D testing (VDT) and supplement use (VDS) are on the rise, but most patients remain deficient (&lt;30 ng/mL-VDD). We designed the present real-world study to assess this paradox.</p><p>Methods: We reviewed data from all patients visiting our clinics between 2014 and 2022. We estimated the rate of patients with vitamin D adequacy (≥30 ng/mL) (VDA) by year and month of testing, the dose of VDS (low (≤1200 IU/day), medium (1201–3000 I/day) and high dose (>3000 IU/day)), intake duration (short-term (&lt;12 months) and long-term use (≥12 months)), and timing of use (current use, former use, no use).</p><p>Results: We enrolled n = 6912 subjects with vitamin D measurements: n = 5195 females (75.2%), age 44.0 ± 16.8 years, BMI 27.9 ± 6.5 kg/m2; never users: n = 5553 (80.3%), former users: n = 533 (7.7%), current users: n = 826 (12.0%). Current use of VDS was higher in females. VDT rose from 42.1% in 2014 to 92.7% in 2022, and VDA rose from 14.8% to 25.5% for the same time. VDA was found overall in n = 1511 (21.9%); Never users: n = 864 (15.6%), Former users: n = 123 (23.2%); and Current users: n = 370 (44.8%). The maximal VDA (67.9%) was found in subjects using high-dose VDS in the long term.</p><p>Conclusions: Despite the significant rise in VDT and VDS use, VDA was found in a minority of patients. Prolonged use of high-dose supplements produces modest improvements in VDA.</p><p><strong><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/intense-testing-compresspdf.pdf>Download the PDF from VitaminDWiki</a></strong></p><pre style=background-color:#e0e0e0;white-space:pre-wrap>
<code class=language-text>
Markdown:
--------
{{&lt; toc &gt;}}

---

#### Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data

Nutrients 2024, 16(1), 111; https://doi.org/10.3390/nu16010111

Rodis D. Paparodis 1,2,3,4,*ORCID,Dimitra Bantouna 3,Evangelos Karvounis 5,Ioannis Zoupas 6ORCID,Sarantis Livadas 3,7,8,Nicholas Angelopoulos 3,9ORCID,Shahnawaz Imam 2ORCID,Dimitrios T. Papadimitriou 3,10ORCID and Juan C. Jaume 4

Background: Vitamin D testing (VDT) and supplement use (VDS) are on the rise, but most patients remain deficient (&lt;30 ng/mL-VDD). We designed the present real-world study to assess this paradox. 

Methods: We reviewed data from all patients visiting our clinics between 2014 and 2022. We estimated the rate of patients with vitamin D adequacy (≥30 ng/mL) (VDA) by year and month of testing, the dose of VDS (low (≤1200 IU/day), medium (1201–3000 I/day) and high dose (&gt;3000 IU/day)), intake duration (short-term (&lt;12 months) and long-term use (≥12 months)), and timing of use (current use, former use, no use). 

Results: We enrolled n = 6912 subjects with vitamin D measurements: n = 5195 females (75.2%), age 44.0 ± 16.8 years, BMI 27.9 ± 6.5 kg/m2; never users: n = 5553 (80.3%), former users: n = 533 (7.7%), current users: n = 826 (12.0%). Current use of VDS was higher in females. VDT rose from 42.1% in 2014 to 92.7% in 2022, and VDA rose from 14.8% to 25.5% for the same time. VDA was found overall in n = 1511 (21.9%); Never users: n = 864 (15.6%), Former users: n = 123 (23.2%); and Current users: n = 370 (44.8%). The maximal VDA (67.9%) was found in subjects using high-dose VDS in the long term. 

Conclusions: Despite the significant rise in VDT and VDS use, VDA was found in a minority of patients. Prolonged use of high-dose supplements produces modest improvements in VDA.

 **&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;&lt;a href=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/intense-testing-compresspdf.pdf&quot;&gt;Download the PDF from VitaminDWiki &lt;/a&gt;** 


AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data`
│   inner_content: `Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data`
│   │   inner_content: `Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data`├── TextNode
│   full_match: `\nNutrients 2024, 16(1), 111; https://doi.org/10.3390/nu16010111\nRodis D. Paparodis 1,2,3,4,*ORCID,Dimitra Bantouna 3,Evangelos Karvounis 5,Ioannis Zoupas 6ORCID,Sarantis Livadas 3,7,8,Nicholas Angelopoulos 3,9ORCID,Shahnawaz Imam 2ORCID,Dimitrios T. Papadimitriou 3,10ORCID and Juan C. Jaume 4\n\nBackground: Vitamin D testing (VDT) and supplement use (VDS) are on the rise, but most patients remain deficient (&lt;30 ng/mL-VDD). We designed the present real-world study to assess this paradox. \n\nMethods: We reviewed data from all patients visiting our clinics between 2014 and 2022. We estimated the rate of patients with vitamin D adequacy (≥30 ng/mL) (VDA) by year and month of testing, the dose of VDS (low (≤1200 IU/day), medium (1201–3000 I/day) and high dose (&gt;3000 IU/day)), intake duration (short-term (&lt;12 months) and long-term use (≥12 months)), and timing of use (current use, former use, no use). \n\nResults: We enrolled n = 6912 subjects with vitamin D measurements: n = 5195 females (75.2%), age 44.0 ± 16.8 years, BMI 27.9 ± 6.5 kg/m2; never users: n = 5553 (80.3%), former users: n = 533 (7.7%), current users: n = 826 (12.0%). Current use of VDS was higher in females. VDT rose from 42.1% in 2014 to 92.7% in 2022, and VDA rose from 14.8% to 25.5% for the same time. VDA was found overall in n = 1511 (21.9%); Never users: n = 864 (15.6%), Former users: n = 123 (23.2%); and Current users: n = 370 (44.8%). The maximal VDA (67.9%) was found in subjects using high-dose VDS in the long term. \n\nConclusions: Despite the significant rise in VDT and VDS use, VDA was found in a minority of patients. Prolonged use of high-dose supplements produces modest improvements in VDA.\n`
│   inner_content: `\nNutrients 2024, 16(1), 111; https://doi.org/10.3390/nu16010111\nRodis D. Paparodis 1,2,3,4,*ORCID,Dimitra Bantouna 3,Evangelos Karvounis 5,Ioannis Zoupas 6ORCID,Sarantis Livadas 3,7,8,Nicholas Angelopoulos 3,9ORCID,Shahnawaz Imam 2ORCID,Dimitrios T. Papadimitriou 3,10ORCID and Juan C. Jaume 4\n\nBackground: Vitamin D testing (VDT) and supplement use (VDS) are on the rise, but most patients remain deficient (&lt;30 ng/mL-VDD). We designed the present real-world study to assess this paradox. \n\nMethods: We reviewed data from all patients visiting our clinics between 2014 and 2022. We estimated the rate of patients with vitamin D adequacy (≥30 ng/mL) (VDA) by year and month of testing, the dose of VDS (low (≤1200 IU/day), medium (1201–3000 I/day) and high dose (&gt;3000 IU/day)), intake duration (short-term (&lt;12 months) and long-term use (≥12 months)), and timing of use (current use, former use, no use). \n\nResults: We enrolled n = 6912 subjects with vitamin D measurements: n = 5195 females (75.2%), age 44.0 ± 16.8 years, BMI 27.9 ± 6.5 kg/m2; never users: n = 5553 (80.3%), former users: n = 533 (7.7%), current users: n = 826 (12.0%). Current use of VDS was higher in females. VDT rose from 42.1% in 2014 to 92.7% in 2022, and VDA rose from 14.8% to 25.5% for the same time. VDA was found overall in n = 1511 (21.9%); Never users: n = 864 (15.6%), Former users: n = 123 (23.2%); and Current users: n = 370 (44.8%). The maximal VDA (67.9%) was found in subjects using high-dose VDS in the long term. \n\nConclusions: Despite the significant rise in VDT and VDS use, VDA was found in a minority of patients. Prolonged use of high-dose supplements produces modest improvements in VDA.\n`├── FontNode
│   full_match: `{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;21421&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;21421&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;17&quot;
│   │   size: 17
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;21421&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;21421&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;21421&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;21421&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 21421
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Optimum)) category contains`
│   inner_content: `VitaminDWiki – ((Optimum)) category contains`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Optimum))`
│   │   inner_content: `Optimum`
│   │   page: `Optimum`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Optimum`
│   │   │   inner_content: `Optimum`
│   ├── TextNode
│   │   full_match: ` category contains`
│   │   inner_content: ` category contains`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Optimum&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Optimum&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Optimum
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Loading Dose of Vitamin D)) category (ignored by the study?)`
│   inner_content: `VitaminDWiki – ((Loading Dose of Vitamin D)) category (ignored by the study?)`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Loading Dose of Vitamin D))`
│   │   inner_content: `Loading Dose of Vitamin D`
│   │   page: `Loading Dose of Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Loading Dose of Vitamin D`
│   │   │   inner_content: `Loading Dose of Vitamin D`
│   ├── TextNode
│   │   full_match: ` category (ignored by the study?)`
│   │   inner_content: ` category (ignored by the study?)`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Loading Dose of Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Loading Dose of Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Loading Dose of Vitamin D
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── TextNode
│   full_match: `\n`
│   inner_content: `\n`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!Intense Testing and Use of Vitamin D Supplements Leads to Slow Improvement in Vitamin D Adequacy Rates: A Cross-Sectional Analysis of Real-World Data
Nutrients 2024, 16(1), 111; https://doi.org/10.3390/nu16010111
 Rodis D. Paparodis 1,2,3,4,*ORCID,Dimitra Bantouna 3,Evangelos Karvounis 5,Ioannis Zoupas 6ORCID,Sarantis Livadas 3,7,8,Nicholas Angelopoulos 3,9ORCID,Shahnawaz Imam 2ORCID,Dimitrios T. Papadimitriou 3,10ORCID and Juan C. Jaume 4

Background: Vitamin D testing (VDT) and supplement use (VDS) are on the rise, but most patients remain deficient (&lt;30 ng/mL-VDD). We designed the present real-world study to assess this paradox. 

Methods: We reviewed data from all patients visiting our clinics between 2014 and 2022. We estimated the rate of patients with vitamin D adequacy (≥30 ng/mL) (VDA) by year and month of testing, the dose of VDS (low (≤1200 IU/day), medium (1201–3000 I/day) and high dose (&gt;3000 IU/day)), intake duration (short-term (&lt;12 months) and long-term use (≥12 months)), and timing of use (current use, former use, no use). 

Results: We enrolled n = 6912 subjects with vitamin D measurements: n = 5195 females (75.2%), age 44.0 ± 16.8 years, BMI 27.9 ± 6.5 kg/m2; never users: n = 5553 (80.3%), former users: n = 533 (7.7%), current users: n = 826 (12.0%). Current use of VDS was higher in females. VDT rose from 42.1% in 2014 to 92.7% in 2022, and VDA rose from 14.8% to 25.5% for the same time. VDA was found overall in n = 1511 (21.9%); Never users: n = 864 (15.6%), Former users: n = 123 (23.2%); and Current users: n = 370 (44.8%). The maximal VDA (67.9%) was found in subjects using high-dose VDS in the long term. 

Conclusions: Despite the significant rise in VDT and VDS use, VDA was found in a minority of patients. Prolonged use of high-dose supplements produces modest improvements in VDA.
{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;21421&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
---
!!!!VitaminDWiki – ((Optimum)) category contains
{include page=&quot;Optimum&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!VitaminDWiki – ((Loading Dose of Vitamin D)) category (ignored by the study?)
{include page=&quot;Loading Dose of Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}

</code>
</pre></article></div></div><script src="/js/lightspa.js?v=1748177522"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748177522",indexUrl:"/search/search_index.json.gz?v=1748177522"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748177522"></script><script src="/js/search-results-panel.js?v=1748177522"></script><script src="/js/tiki-redirects.js?v=1748177522"></script></body></html>